Fujii Chihiro 藤井ちひろ

Researcher Number	00516065
Other IDs	https://orcid.org/0009-0006-5117-0845
Affiliation (Current)	2025: 関西医科大学, 医学部, 講師 2025: 京都府立医科大学, 医学(系)研究科(研究院), 客員講師
Affiliation (based on the past Project Information) *help	2022 – 2023: 京都府立医科大学, 医学(系)研究科(研究院), 客員講師 2019 – 2021: 京都府立医科大学, 医学部附属病院, 専攻医 2019 – 2020: 京都府立医科大学, 医学(系)研究科(研究院), 特任助教 2018: 京都府立医科大学, 医学(系)研究科(研究院), 助教 2017: 京都府立医科大学, 医学(系)研究科(研究院), 研究員 2017: 京都府立医科大学, 医学部附属病院, 研究員 2016: 京都府立医科大学, 医学部附属病院, 専攻医
Review Section/Research Field	Principal Investigator Basic Section 51030:Pathophysiologic neuroscience-related / Medical pharmacy Except Principal Investigator Basic Section 52020:Neurology-related
Keywords	Principal Investigator precision medicine / red flags / disease modifying drugs / biomarker / immunological diversity / clinical diversity / multiple sclerosis / 免疫学 / 疾患修飾薬 / IFN-γ … More / MBP反応性T細胞 / IFN‐γ / 細胞障害性分子 / fingolimod / CD56陽性T細胞 / バイオマーカー / T細胞 / フィンゴリモド / 多発性硬化症 … More Except Principal Investigator 個別化治療 / 疾患活動性 / 免疫モニタリング / NfL / GFAP / 濾胞性ヘルパーT細胞 / IL6 / B細胞 / 補体 / 末梢性ヘルパーT細胞 / 末梢血濾胞性ヘルパーT細胞 / アストロサイト / AQP4抗体 / 視神経脊髄炎 / IL-10 / Toll様受容体 / Toll様受容体４ / リポ多糖結合タンパク質 / HMGB1 / リポ多糖結合蛋白質 / リポ多糖 / IL10 / 制御性B細胞 / Toll様受容体4 / 多発性硬化症 Less

Immunological monitoring of neuromyelitis optica activity via peripheral blood circulating follicular helper T cell
- Principal Investigator
  
  Ochi Hirofumi
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52020:Neurology-related
- Research Institution
  Ehime University
Investigation of immunopathogenic diversity contributing to clinical heterogeneity in multiple sclerosisPrincipal Investigator
- Principal Investigator
  
  Fujii Chihiro
- Project Period (FY)
  2019 – 2023
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 51030:Pathophysiologic neuroscience-related
- Research Institution
  Kyoto Prefectural University of Medicine
Novel therapy for multiple sclerosis via induction of regulatory B cells targeting Toll-like receptor
- Principal Investigator
  
  Ochi Hirofumi
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52020:Neurology-related
- Research Institution
  Ehime University
Investigation of biomarkers to select the optimal disease-modifying drugs for each individual patient with multiple sclerosis.Principal Investigator
- Principal Investigator
  
  Fujii Chihiro
- Project Period (FY)
  2016 – 2017
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Medical pharmacy
- Research Institution
  Kyoto Prefectural University of Medicine

All 2023 2022 2021 2017 2016

All Journal Article Presentation

[Journal Article] Urosepsis Risk in Neuromyelitis Optica Spectrum Disorder Patients Administered Satralizumab2023
- Author(s)
  Fujita Rina、Aratake Yuriko、Nakata Kyoko、Fujii Chihiro、Kondo Takayuki
- Journal Title
  
  Intern. Med.
  
  Volume: 62 Issue: 22 Pages: 3317-3320
- DOI
  10.2169/internalmedicine.1642-23
- ISSN
  0918-2918, 1349-7235
- Year and Date
  2023-11-15
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K16923
[Journal Article] Association of cerebrospinal inflammatory profile with radiological features in newly diagnosed treatment-naive patients with multiple sclerosis2022
- Author(s)
  Ashida Shinji, Kondo Takayuki, Fujii Chihiro, Hamatani Mio, Mizuno Toshiki, Ochi Hirofumi
- Journal Title
  
  Frontiers in Neurology
  
  Volume: 13 Pages: 1012857-1012857
- DOI
  10.3389/fneur.2022.1012857
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07463, KAKENHI-PROJECT-19K16923
[Journal Article] Radiological and Laboratory Features of Multiple Sclerosis Patients With Immunosuppressive Therapy: A Multicenter Retrospective Study in Japan2021
- Author(s)
  Ashida Shinji、Ochi Hirofumi、Hamatani Mio、Fujii Chihiro、Nishigori Ryusei、Kawamura Kazuyuki、Matsumoto Sadayuki、Nakagawa Masanori、Takahashi Ryosuke、Mizuno Toshiki、Kondo Takayuki
- Journal Title
  
  Frontiers in Neurology
  
  Volume: 12 Pages: 749406-749406
- DOI
  10.3389/fneur.2021.749406
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07463
[Presentation] サトラリズマブ投与下視神経脊髄炎スペクトラム障害における敗血症の臨床的特徴の検討2023
- Author(s)
  藤井ちひろ
- Organizer
  第35回日本神経免疫学会学術集会
- Data Source
  KAKENHI-PROJECT-19K16923
[Presentation] 非典型的な頭部MRI画像所見を有する多発性硬化症に対するオファツズマブの有効性の検討2022
- Author(s)
  荒武由利子、藤井ちひろ、藤田理奈、篠藤裕也、井谷久美、濱谷美緒、峠理絵、近藤誉之
- Organizer
  第34回神経免疫学会学術集会
- Data Source
  KAKENHI-PROJECT-19K16923
[Presentation] レッドフラッグを有する多発性硬化症の判別における髄液サイトカイン・ケモカイン解析の有用性の検討2021
- Author(s)
  芦田真士　藤井ちひろ　越智博文　濱谷美緒　錦織隆成　高田真基　高橋良輔　水野敏樹　近藤誉之
- Organizer
  第33回神経免疫学会学術集会
- Data Source
  KAKENHI-PROJECT-19K16923
[Presentation] 多発性硬化症におけるRed Flagsと治療反応性の検討2017
- Author(s)
  芦田真士, 濱谷美緒, 藤井ちひろ, 岡田洋一郎, 端祐一郎, 松本禎之, 水野敏樹, 中川正法, 高橋良輔, 近藤誉之
- Organizer
  第29回日本神経免疫学会　北海道
- Data Source
  KAKENHI-PROJECT-16K21285
[Presentation] Elevated frequency of CD56+ T cells in neuromyelitis optica spectrum disorder and multiple sclerosis with “Red flags”.2017
- Author(s)
  Fujii C, Kondo T, Ochi H, Okada Y, Hashi Y, Matsumoto S, Takahashi R, Nakagawa M, Mizuno T.
- Organizer
  The 23rd World Congress of Neurology (WCN) 2017. Kyoto, Japan
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K21285
[Presentation] Association of red flags with therapeutic reactivity in Multiple sclerosis.2017
- Author(s)
  Ashida S, Hamatani M, Ochi H, Fujii C, Okada Y, Hashi Y, Kawamura K, Matsumoto S, Kusaka H, Takahashi R, Nakagawa M, Mizuno T, Kondo T.
- Organizer
  The 23rd World Congress of Neurology (WCN) 2017. Kyoto, Japan
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K21285
[Presentation] CD56 positivity of T cells as a candidate of a predictive biomarker for relapse of multiple sclerosis under fingolimod therapy.2016
- Author(s)
  Chihiro Fujii
- Organizer
  32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis（ECTRIMS）
- Place of Presentation
  London, UK
- Year and Date
  2016-09-15
- Data Source
  KAKENHI-PROJECT-16K21285
[Presentation] Fingolimod治療下多発性硬化症の再発例におけるCD56+T細胞の経時的変化.2016
- Author(s)
  藤井　ちひろ
- Organizer
  第57 回日本神経学会学術集会
- Place of Presentation
  神戸コンベンションセンター
- Year and Date
  2016-05-19
- Data Source
  KAKENHI-PROJECT-16K21285

1. Ochi Hirofumi (20325442)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
2. 岡田洋一郎 (10808356)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. 濱谷美緒 (20890809)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 芦田真士 (60884202)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results

Fujii Chihiro 藤井 ちひろ

Research Projects

Research Products

Co-Researchers

Immunological monitoring of neuromyelitis optica activity via peripheral blood circulating follicular helper T cell

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Investigation of immunopathogenic diversity contributing to clinical heterogeneity in multiple sclerosisPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Novel therapy for multiple sclerosis via induction of regulatory B cells targeting Toll-like receptor

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Investigation of biomarkers to select the optimal disease-modifying drugs for each individual patient with multiple sclerosis.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Urosepsis Risk in Neuromyelitis Optica Spectrum Disorder Patients Administered Satralizumab2023

Author(s)

Journal Title

DOI

ISSN

Year and Date

Language

Data Source

[Journal Article] Association of cerebrospinal inflammatory profile with radiological features in newly diagnosed treatment-naive patients with multiple sclerosis2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Radiological and Laboratory Features of Multiple Sclerosis Patients With Immunosuppressive Therapy: A Multicenter Retrospective Study in Japan2021

Author(s)

Journal Title

DOI

Data Source

[Presentation] サトラリズマブ投与下視神経脊髄炎スペクトラム障害における敗血症の臨床的特徴の検討2023

Author(s)

Organizer

Data Source

[Presentation] 非典型的な頭部MRI画像所見を有する多発性硬化症 に対するオファツズマブの有効性の検討2022

Author(s)

Organizer

Data Source

[Presentation] レッドフラッグを有する多発性硬化症の判別における 髄液サイトカイン・ケモカイン解析の有用性の検討2021

Author(s)

Organizer

Data Source

[Presentation] 多発性硬化症におけるRed Flagsと治療反応性の検討2017

Author(s)

Organizer

Data Source

[Presentation] Elevated frequency of CD56+ T cells in neuromyelitis optica spectrum disorder and multiple sclerosis with “Red flags”.2017

Author(s)

Organizer

Data Source

[Presentation] Association of red flags with therapeutic reactivity in Multiple sclerosis.2017

Author(s)

Organizer

Data Source

[Presentation] CD56 positivity of T cells as a candidate of a predictive biomarker for relapse of multiple sclerosis under fingolimod therapy.2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Fingolimod治療下多発性硬化症の再発例におけるCD56+T細胞の経時的変化.2016

Author(s)

Organizer

Place of Presentation

Fujii Chihiro 藤井ちひろ

[Presentation] 非典型的な頭部MRI画像所見を有する多発性硬化症に対するオファツズマブの有効性の検討2022

[Presentation] レッドフラッグを有する多発性硬化症の判別における髄液サイトカイン・ケモカイン解析の有用性の検討2021